These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 16837684

  • 21. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH.
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract] [Full Text] [Related]

  • 22. A STARring role for raloxifene?
    Lancet Oncol; 2006 Jun; 7(6):443. PubMed ID: 16750489
    [No Abstract] [Full Text] [Related]

  • 23. Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.
    Johnell O, Cauley JA, Kulkarni PM, Wong M, Stock JL.
    J Fam Pract; 2004 Oct; 53(10):789-96. PubMed ID: 15469774
    [Abstract] [Full Text] [Related]

  • 24. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract] [Full Text] [Related]

  • 25. [SERM--selective estrogen receptor modulators].
    Kønig KB, Eiken PA, Schwarz P.
    Ugeskr Laeger; 2001 Apr 09; 163(15):2129-33. PubMed ID: 11332210
    [Abstract] [Full Text] [Related]

  • 26. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL, Cheng MH, Chao HT, Wang PH.
    Taiwan J Obstet Gynecol; 2008 Mar 09; 47(1):24-31. PubMed ID: 18400579
    [Abstract] [Full Text] [Related]

  • 27. [Selective estrogen receptor modulators (SERMs)].
    Matsumoto T.
    Clin Calcium; 2006 Sep 09; 16(9):1520-25. PubMed ID: 16951478
    [Abstract] [Full Text] [Related]

  • 28. [SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half].
    MMW Fortschr Med; 2003 May 29; 145(22):57. PubMed ID: 12866287
    [No Abstract] [Full Text] [Related]

  • 29. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct 29; 10(2):1-2. PubMed ID: 12393316
    [No Abstract] [Full Text] [Related]

  • 30. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T, Mizunuma H.
    Clin Calcium; 2004 Oct 29; 14(10):81-4. PubMed ID: 15577136
    [Abstract] [Full Text] [Related]

  • 31. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
    Mobasseri S, Liebson PR, Klein LW.
    Cardiol Rev; 2004 Oct 29; 12(6):287-98. PubMed ID: 15476565
    [Abstract] [Full Text] [Related]

  • 32. The rise of raloxifene and the fall of invasive breast cancer.
    Jordan VC.
    J Natl Cancer Inst; 2008 Jun 18; 100(12):831-3. PubMed ID: 18544739
    [No Abstract] [Full Text] [Related]

  • 33. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec 18; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 34. Raloxifene: bone and cardiovascular effects.
    Francucci CM, Romagni P, Boscaro M.
    J Endocrinol Invest; 2005 Dec 18; 28(10 Suppl):85-9. PubMed ID: 16550730
    [Abstract] [Full Text] [Related]

  • 35. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan 18; 18(11):1-2. PubMed ID: 17323491
    [No Abstract] [Full Text] [Related]

  • 36. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ, Craig Jordan V.
    Minerva Endocrinol; 2002 Jun 18; 27(2):127-39. PubMed ID: 11961504
    [Abstract] [Full Text] [Related]

  • 37. [Effects of SERMs on bone health. Raloxifene effects on breast cancer and cardiovascular events].
    Inoue D.
    Clin Calcium; 2010 Mar 18; 20(3):331-8. PubMed ID: 20190362
    [Abstract] [Full Text] [Related]

  • 38. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ.
    Breast Cancer Res; 2006 Mar 18; 8(5):111. PubMed ID: 17049068
    [Abstract] [Full Text] [Related]

  • 39. [Effects of raloxifene on other organs without bone: uterus].
    Nozaki M.
    Clin Calcium; 2004 Oct 18; 14(10):55-60. PubMed ID: 15577132
    [Abstract] [Full Text] [Related]

  • 40. Summaries for patients. Using medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2013 Nov 19; 159(10):I-28. PubMed ID: 24400336
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.